Canada’s 2021 federal budget announced a $400M investment over six years for a new Pan-Canadian Genomics Strategy (PCGS) to advance the translation and commercialization of genomics and related technologies to drive economic growth, strengthen Canada's global leadership, and position Canada for long-term success in the global bioeconomy, while enhancing ecosystem coherence and coordination. $136.7M of this was invested in Genome Canada’s new Challenge-driven approach.
After consultations with key stakeholders in May & June of 2022, the Pan-Canadian Genomics Strategy – What We Heard Report was released by the Department of Innovation, Science and Economic Development Canada in early 2023, highlighting key challenges, opportunities and priority areas for building a strong genomics future for Canada.
WHAT YOU'LL LEARN IN THIS SESSION
- Ecosystem context: key themes and findings from the PCGS consultations
- Strategic programming at Genome Canada: Rising to the Challenge
- Genomics data – key issues, opportunities and challenges in the Canadian landscape
- Highlights of Genome Canada initiatives and next steps
About OUR Speakers
Vice-President, Policy and Public Affairs, Genome Canada
Pari was a founding board member of The Conversation Canada/La Conversation Canada, the national digital media organization for academic journalism. A passionate community volunteer, she serves on the Board of Trustees of the Royal Ottawa Mental Health Care Centre. She founded Housing Through an Autism Lens, a national solutions lab designed to create solutions to housing challenges faced by autistic adults in Ottawa.
Associate Vice-President, Genomics Programs, Genome Canada
Before she joined the Genome Canada team in 2005, Karen was a Deputy Director in the Research Portfolio at the Canadian Institutes of Health Research (CIHR), where she managed the peer-review process for a portfolio of programs and liaised with a suite of CIHR institutes on peer-review activities related to strategic initiatives.